Berberine inhibited the growth of thyroid cancer cell lines 8505C and TPC1

Yonsei Medical Journal

Volumn 53, Issue 2, 2012, Pages 346-351

  Park, Kyoung Sik ^a   Kim, Jong Bin ^a   Bae, Jaeman ^a   Park, Seo Young ^b   Jee, Hyeon Gun ^b   Lee, Kyu Eun ^b   Youn, Yeo Kyu ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Anticancer drug; Berberine; Growth; Thyroid cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BERBERINE; PROTEIN P27;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL 8505C; CANCER CELL CULTURE; CANCER CELL TPC1; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; DOSE RESPONSE; ENZYME INDUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; PROTEIN EXPRESSION; THYROID CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BERBERINE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; THYROID NEOPLASMS;

EID: 84863169304     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2012.53.2.346     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, et al. Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat 2009;41:122-31.
3. Jantová S, Cipák L, Cernáková M, Kost'álová D. Effect of berber-ine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. J Pharm Pharmacol 2003;55:1143-9.
4. Hu Z, Jiao Q, Ding J, Liu F, Liu R, Shan L, et al. Berberine induces dendritic cell apoptosis and has therapeutic potential for rheumatoid arthritis. Arthritis Rheum 2011;63:949-59.
5. Abidi P, Zhou Y, Jiang JD, Liu J. Extracellular signal-regulated ki-nase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler Thromb Vasc Biol 2005;25:2170-6.
6. Leng SH, Lu FE, Xu LJ. Therapeutic effects of berberine in impaired glucose tolerance rats and its infuence on insulin secretion. Acta Pharmacol Sin 2004;25:496-502.
7. Inoue K, Kulsum U, Chowdhury SA, Fujisawa S, Ishihara M, Yo-koe I, et al. Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines. Anticancer Res 2005;25:4053-9.
8. Peng PL, Hsieh YS, Wang CJ, Hsu JL, Chou FP. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol Appl Pharmacol 2006;214:8-15.
9. Orfila L, Rodríguez M, Colman T, Hasegawa M, Merentes E, Arvelo F. Structural modifcation of berberine alkaloids in relation to cytotoxic activity in vitro. J Ethnopharmacol 2000;71:449-56.
10. Jantová S, Letasiová S, Brezová V, Cipák L, Lábaj J. Photochemical and phototoxic activity of berberine on murine fbroblast NIH-3T3 and Ehrlich ascites carcinoma cells. J Photochem Photobiol B 2006;85:163-76.
11. Katiyar SK, Meeran SM, Katiyar N, Akhtar S. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinog 2009;48:24-37.
12. Mantena SK, Sharma SD, Katiyar SK. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 2006;27:2018-27.
13. Lin CC, Kao ST, Chen GW, Ho HC, Chung JG. Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Anticancer Res 2006;26:227-42.
14. Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer 2011;10:39.
15. Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, et al. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine 2010;17:436-40.
16. Hoffmann S, Burchert A, Wunderlich A, Wang Y, Lingelbach S, Hofbauer LC, et al. Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endo-thelial growth factor receptor (VEGF-R) in thyroid cancer cell lines. Endocrine 2007;31:105-13.
17. Kang MR, Chung IK. Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a proto-berberine alkaloid, berberrubine. Mol Pharmacol 2002;61:879-84.
18. Lin CC, Lin SY, Chung JG, Lin JP, Chen GW, Kao ST. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle. Anticancer Res 2006;26:1097-104.
19. Bhatt KV, Hu R, Spofford LS, Aplin AE. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells. Oncogene 2007;26:1056-66.
20. Bhatt KV, Spofford LS, Aram G, McMullen M, Pumiglia K, Aplin AE. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling. Oncogene 2005;24:3459-71.
21. Preto A, Gonçalves J, Rebocho AP, Figueiredo J, Meireles AM, Rocha AS, et al. Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations. BMC Cancer 2009;9:387.
22. Letasiová S, Jantová S, Miko M, Ovádeková R, Horváthová M. Effect of berberine on proliferation, biosynthesis of macromole-cules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells. J Pharm Pharmacol 2006;58:263-70.
23. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for fow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-20.